Here are five points:
1. NuVasive accounts for 0.3 percent of Quantitative Systematic Strategies’ holdings.
2. The firm has an average rating of “buy” and an average target price of $58.54.
3. The company’s 50-day moving average is $47.93, and its 200-day moving average is $50.81.
4. NuVasive has a 52-week low of $36.81 and a 52-week high of $56.61.
5. The firm has a market capitalization of $1.94 billion.
More articles on devices:
43 spine, orthopedic devices receive FDA 510(k) clearance in January
Foot and ankle market to reach $5.4B in 2020 — 4 insights
Wright Medical Group shares receive average price target of $28.11: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
